サイクリン依存性キナーゼ阻害剤のパイプライン・インサイト2018

調査会社DelveInsight社が発行したリサーチレポート(データ管理コード:DIMR2016215)
◆英語タイトル:Cyclin-Dependent Kinases (CDKs) Inhibitors -Pipeline Insights, 2018
◆発行会社/調査会社:DelveInsight
◆商品コード:DIMR2016215
◆発行日:2019年02月
◆調査対象地域:グローバル
◆産業分野:製薬
◆ページ数:約60
◆レポート言語:英語
◆レポート形式:PDF
◆納品方式:Eメール(受注後3営業日)
◆販売価格オプション(消費税別)
Single User(1名使用)USD1,250 ⇒換算¥136,250見積依頼/購入/質問フォーム
Site Price(同一国内共有可)USD2,500 ⇒換算¥272,500見積依頼/購入/質問フォーム
Enterprise Price(複数国内共有可)USD4,000 ⇒換算¥436,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
DelveInsight社の概要及び新刊レポートはこちらでご確認いただけます。

★グローバルリサーチ資料[サイクリン依存性キナーゼ阻害剤のパイプライン・インサイト2018]についてメールでお問い合わせはこちら
本調査レポートでは、世界におけるサイクリン依存性キナーゼ阻害剤のパイプライン動向について調査・分析し、以下の構成でお届けいたします。

・サイクリン依存性キナーゼ阻害剤の概要
・サイクリン依存性キナーゼ阻害剤のパイプライン概要
・企業別開発中のサイクリン依存性キナーゼ阻害剤
・後期治験段階の薬剤(Filed & Phase III):比較分析
・中期治験段階の薬剤(Phase II):比較分析
・初期治験段階の薬剤(Phase I & IND Filed):比較分析
・薬剤候補のプロファイル
・サイクリン依存性キナーゼ阻害剤の評価
  - 単剤治療薬別評価
  - 併用治療薬別評価
  - 投与経路別評価
  - 分子種類別評価
・開発が中止された薬剤リスト
・開発休止中の薬剤リスト
・サイクリン依存性キナーゼ阻害剤開発に取り組んでいる企業リスト
・図表一覧
*** レポート概要(サマリー)***

SUMMARY
DelveInsight’s, “Cyclin-Dependent Kinases (CDKs) Inhibitors-Pipeline Insights, 2018”, report provides in depth insights on the pipeline drugs and their development activities around the Cyclin-Dependent Kinases (CDKs) Inhibitors. The DelveInsight’s Report covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA designations details. DelveInsight’s Report also provides detailed information on the discontinued and dormant drugs that have gone inactive over the years for Cyclin-Dependent Kinases (CDKs) Inhibitors. DelveInsight’s Report also assesses the Cyclin-Dependent Kinases (CDKs) Inhibitors therapeutics by Monotherapy, Combination products, Molecule type and Route of Administration.

Please note: This report requires certain updates. We have all the information available but require 3 business days to complete the process and ensure it is as up-to-date as possible. Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated indication.


Scope
• The report provides competitive pipeline landscape of Cyclin-Dependent Kinases (CDKs) Inhibitors
• The report provides pipeline products under drug profile section which includes product description, MOA, licensors & collaborators, development partner and chemical information
• Coverage of the Cyclin-Dependent Kinases (CDKs) Inhibitors pipeline on the basis of target, MOA, route of administration, technology involved and molecule type
• The report reviews key players involved in the therapeutics development for Cyclin-Dependent Kinases (CDKs) Inhibitors and also provide company profiling
• The report also gives the information of dormant and discontinued pipeline projects
• Pipeline products coverage based on various stages of development ranging from preregistration till discovery and undisclosed stages
• Provides pipeline assessment by monotherapy and combination therapy products, stage of development and molecule type


*** レポート目次(コンテンツ)***

Table of Contents
• Cyclin-Dependent Kinases (CDKs) Inhibitors Overview
• Cyclin-Dependent Kinases (CDKs) Inhibitors Disease Associated
• Cyclin-Dependent Kinases (CDKs) Inhibitors Pipeline Therapeutics
• Cyclin-Dependent Kinases (CDKs) Inhibitors Therapeutics under Development by Companies
• Cyclin-Dependent Kinases (CDKs) Inhibitors Filed and Phase III Products
• Comparative Analysis
• Cyclin-Dependent Kinases (CDKs) Inhibitors Phase II Products
• Comparative Analysis
• Cyclin-Dependent Kinases (CDKs) Inhibitors Phase I and IND Filed Products
• Comparative Analysis
• Cyclin-Dependent Kinases (CDKs) Inhibitors Discovery and Pre-Clinical Stage Products
• Comparative Analysis
• Drug Candidate Profiles
• Cyclin-Dependent Kinases (CDKs) Inhibitors – Therapeutics Assessment
• Assessment by Monotherapy Products
• Assessment by Combination Products
• Assessment by Route of Administration
• Assessment by Molecule Type
• Cyclin-Dependent Kinases (CDKs) Inhibitors – Discontinued Products
• Cyclin-Dependent Kinases (CDKs) Inhibitors – Dormant Products
• Companies Involved in Therapeutics Development for Cyclin-Dependent Kinases (CDKs) Inhibitors
• Appendix
• Methodology
• Contact Us
• Disclaimer

List of Tables
• Number of Products under Development for Cyclin-Dependent Kinases (CDKs) Inhibitors by Therapy Area, 2018
• Number of Products under Development for Cyclin-Dependent Kinases (CDKs) Inhibitors, 2018
• Number of Products under Development by Companies
• Comparative Analysis by Filed and Phase III Products, 2018
• Comparative Analysis Phase II Products, 2018
• Comparative Analysis Phase I and IND Filed Products, 2018
• Comparative Analysis Discovery and Pre-Clinical Stage Products, 2018
• Drug Candidates Profiles
• Cyclin-Dependent Kinases (CDKs) Inhibitors Assessment by Monotherapy Products
• Cyclin-Dependent Kinases (CDKs) Inhibitors Assessment by Combination Products
• Cyclin-Dependent Kinases (CDKs) Inhibitors Assessment by Route of Administration
• Cyclin-Dependent Kinases (CDKs) Inhibitors Assessment by Stage and Route of Administration
• Cyclin-Dependent Kinases (CDKs) Inhibitors Assessment by Molecule Type
• Cyclin-Dependent Kinases (CDKs) Inhibitors Assessment by Stage and Molecule Type
• Cyclin-Dependent Kinases (CDKs) Inhibitors Therapeutics – Discontinued Products
• Cyclin-Dependent Kinases (CDKs) Inhibitors Therapeutics – Dormant Products
• Products under Development by Companies, 2018


List of Figures
• Number of Products under Development for Cyclin-Dependent Kinases (CDKs) Inhibitors by Therapy Area, 2018
• Number of Products under Development for Cyclin-Dependent Kinases (CDKs) Inhibitors, 2018
• Filed and Phase III Products, 2018
• Phase II Products, 2018
• Phase I and IND Filed Products, 2018
• Discovery and Pre-Clinical Stage Products, 2018
• Cyclin-Dependent Kinases (CDKs) Inhibitors Assessment by Monotherapy Products
• Cyclin-Dependent Kinases (CDKs) Inhibitors Assessment by Combination Products
• Cyclin-Dependent Kinases (CDKs) Inhibitors Assessment by Route of Administration
• Cyclin-Dependent Kinases (CDKs) Inhibitors Assessment by Stage and Route of Administration
• Cyclin-Dependent Kinases (CDKs) Inhibitors Assessment by Molecule Type
• Cyclin-Dependent Kinases (CDKs) Inhibitors Assessment by Stage and Molecule Type


*** レポートのキーワード ***

サイクリン依存性キナーゼ阻害剤、医薬品、製薬、研究開発、パイプライン、治療、治験

*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/


※おすすめ調査資料
  • China CITIC Bank Corporation Limited (601998):企業概要及びSWOT分析
    World Market Intelligence's "China CITIC Bank Corporation Limited (601998) - Company Profile and SWOT Analysis" contains in depth information and data about the company and its operations. The profile contains a company overview, key facts, major products and services, SWOT analysis, business descri …
  • 2014 Opportunities in the Japanese Clinical Chemistry and Immunodiagnostics Market
    Complete report $7,600.  DataPack (test volumes, sales forecasts, supplier shares) $4,900.[u]“[/u]2014 Opportunities in the Japanese Clinical Chemistry and Immunodiagnostic Market” is a new strategic analysis of major business opportunities emerging in the Japanese clinical chemistr …
  • スペインの有機質肥料市場
    The report presents analysis of organic fertilizer market in Spain. Scope Brief country profile includes general information and main economic indicators and specifies business environment in Spain Organic Fertilizer market is analyzed by different parameters including domestic production and consum …
  • ルーマニアのナッツ及びカーネル市場
    The report presents analysis of nuts and kernels market in Romania. Scope Brief country profile includes general information and main economic indicators and specifies business environment in Romania Nuts and Kernels market is analyzed by different parameters including domestic production and consum …
  • ドイツの抵抗器市場(~2019):市場規模、動向、予測
    The report Electrical Resistor Market in Germany to 2020 - Market Size, Development, and Forecasts offers the most up-to-date industry data on the actual market situation, and future outlook for electrical resistors in Germany. The research includes historic data from 2009 to 2015 and forecasts unti …
  • ペルーの養鶏機械市場(~2019)
    The industry report Poultry-Keeping Machine Market in Peru to 2019 - Market Size, Development, and Forecasts offers the most up-to-date market data on the actual market situation, and future outlook for poultry-keeping machines in Peru. The research includes historic market data from 2008 to 2014 an …
  • 世界及び中国のテトラヒドロフラン-3-オール市場2016
    The 'Global and Chinese 3-Hydroxytetrahydrofuran Industry, 2016 Market Research Report' is a professional and in-depth study on the current state of the global 3-Hydroxytetrahydrofuran industry with a focus on the Chinese market. The report provides key statistics on the market status of the 3-Hydro …
  • 産業用イーサネットの世界市場予測
    Market Synopsis Industrial Ethernet is a communication device that uses the EtherNet/IP, PROFINET, EtherCAT, Modbus TCP, POWERLINK, Sercos III, and CC-Link IE industrial protocols. These protocols allow for real-time control over network communication in the automotive, electrical and electronics, a …
  • 衛星トランスポンダの世界市場見通し2017-2026
    According to Stratistics MRC, the Global Satellite Transponder Market is accounted for $15.35 billion in 2017 and is expected to reach $28.65 billion by 2026 growing at a CAGR of 7.1% during the forecast period. Factors such as growth in KU-band & Ka-band services, technology upgrades in VSAT system …
  • ブイヨン及びストック(Bouillons & Stocks )食品市場(~2017):メキシコ
    Synopsis The report presents detailed data on consumption trends in the Bouillons and Stocks category in Mexico, analyzing consumption volumes and values at segment level. It also provides indispensable data on distribution channels along with latest industry news and mergers and acquisitions (of Se …
※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
※当市場調査資料(DIMR2016215 )"サイクリン依存性キナーゼ阻害剤のパイプライン・インサイト2018" (英文:Cyclin-Dependent Kinases (CDKs) Inhibitors -Pipeline Insights, 2018)はDelveInsight社が調査・発行しており、H&Iグローバルリサーチが販売します。


◆H&Iグローバルリサーチのお客様(例)◆


※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
※H&Iグローバルリサーチ(登録第5864124号)及びH&I(登録第5783645号)はH&Iグローバルリサーチ株式会社の商標です。